Search

Search Constraints

You searched for: Author/Creator Ruscito, Ilary

Search Results

1. Advances in anti-angiogenic agents for ovarian cancer treatment: The role of trebananib (AMG 386). Issue 3 (June 2015)

2. Beyond circulating microRNA biomarkers: Urinary microRNAs in ovarian and breast cancer. Issue 5 (April 2017)

3. BRCA1 Promoter Methylation and Clinical Outcomes in Ovarian Cancer: An Individual Patient Data Meta-Analysis. (15th May 2020)

4. Exploring the clonal evolution of CD133/aldehyde-dehydrogenase-1 (ALDH1)-positive cancer stem-like cells from primary to recurrent high-grade serous ovarian cancer (HGSOC). A study of the Ovarian Cancer Therapy–Innovative Models Prolong Survival (OCTIPS) Consortium. (July 2017)

5. Genetic Versus Epigenetic BRCA1 Silencing Pathways: Clinical Effects in Primary Ovarian Cancer Patients. Issue 8 (1st October 2017)

6. Genetic Versus Epigenetic BRCA1 Silencing Pathways: Clinical Effects in Primary Ovarian Cancer Patients. Issue 8 (October 2017)

8. Impact of clinical factors and surgical outcome on long-term survival in high-grade serous ovarian cancer: a multicenter analysis. Issue 5 (9th February 2021)

9. Impact of clinical factors and surgical outcome on long-term survival in high-grade serous ovarian cancer: a multicenter analysis. Issue 5 (9th February 2021)

10. Impact of clinical factors and surgical outcome on long‐term survival in high‐grade serous ovarian cancer: a multicenter analysis. Issue 5 (May 2021)